semaglutide and vision loss linked to higher risk of problems, FDA data analysis shows Ozempic Vision Loss: What Patients
Description
Adverse events associated with EGD and EGD-related techniques

TRIUMPH-1 and TRIUMPH-2 are the pivotal trials, the ones Lilly will submit to the FDA to get retatrutide approved
For individuals who appear healthy by BMI standards but struggle with energy crashes, prediabetic glucose patterns, or family histories of type 2 diabetes, GLP-1 therapy addresses root causes rather than cosmetic metrics

Diet and Exercise Aren't Enough: Traditional weight loss methods are less effective at reducing visceral fat compared to the fat under your skin (subcutaneous fat)

And weight loss, if its going to happen, usually takes a month or two to start and plateaus at around eight months
